Tratamiento no quirúrgico: Watch and wait

Autores/as

  • P. J. Paredes Cotoré Complejo Hospitalario Universitario de Santiago. Área Sanitaria de Santiago de Compostela e Barbanza
  • A. Parajó Calvo Hospitalario Universitario. Área Sanitaria de Pontevedra e O Salnés
  • J. E. Casal Núñez Complejo Hospitalario Universitario de Vigo. Área Sanitaria de Vigo

Palabras clave:

cáncer de recto, Cirugía colorrectal

Resumen

Artículo especial: capítulo 10 de la “Guía práctica para el tratamiento quirúrgico del cáncer de recto" del Grupo Gallego de Coloproctología y la Sociedad de Cirugía de Galicia.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Hartley A., Ho K. F., McConkey C., Geh J. I. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol. 2005; 78:934-8. Doi: 10.1259/bjr/86650067.

Belluco C., De Paoli A., Canzonieri V., Sigon R., Fornasarig M., Buonadonna A., et al. Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Ann Surg Oncol. 2011; 18:3686-93. Doi: 10.1245/s10434-011-1822-0.

Fokas E., Appelt A., Glynne Jóns R., Beets G., Pérez R., García Aguilar J., et al. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer. Nat Rev Clin Oncol. 2021; 18:805-16. Doi: 10.1038/s41571-021-00538-5. PMID: 34349247.

Hiotis S. P., Weber S. M., Cohen A. M., Minsky B. D., Paty P. B., Guillem J. G., et al. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg. 2002; 194:131-5; discussion 135-6. Doi: 10.1016/s1072-7515(01)01159-0. PMID: 11848629.

Swellengrebel H. A., Bosch S. L., Cats A., Vincent A. D., Dewit L. G., Verwaal V. J., et al. Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome. Radiother Oncol. 2014; 112:44-51. Doi: 10.1016/j.radonc.2014.05.010. PMID: 25018000.

Park I. J., You Y. N., Skibber J. M., Rodríguez Bigas M. A., Feig B., Nguyen S., et al. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Dis Colon Rectum. 2013; 56:135-41. Doi: 10.1097/DCR.0b013e318278ff8a.

Habr Gama A., Pérez R. O., Proscurshim I., Campos F. G., Nadalin W., Kiss D., Gama Rodrigues J. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg. 2006; 10:1319-28; discussion 1328-9. Doi: 10.1016/j.gassur.2006.09.005.

López Campos F., Martín Martín M., Fornell Pérez R., García Pérez J. C., DieTrill J., Fuentes Mateos R., et al. Watch and wait approach in rectal cancer: Current controversies and future directions. World J Gastroenterol. 2020; 26:4218-39. Doi: 10.3748/ wjg.v26.i29.4218.

Bernier L., Balyasnikova S., Tait D., Brown G. Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer. Curr Colorectal Cancer Rep. 2018; 14:37-55. Doi: 10.1007/s11888-018-0398-5.

van der Valk M. J. M., Hilling D. E., Bastiaannet E., Meershoek Klein Kranenbarg E., Beets G. L., Figueiredo N. L., et al. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 2018; 391:2537-45. Doi: 10.1016/S0140-6736(18)31078-X.

Cerdán Santacruz C., Vailati B. B., São Julião G. P., Habr Gama A., Pérez R. O. Watch and wait: Why, to whom and how. Surg Oncol. 2022 Aug; 43:101774. Doi: 10.1016/j.suronc.2022.101774.

Renehan A. G., Malcomson L., Emsley R., Gollins S., Maw A., Myint A. S., et al. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Lancet Oncol. 2016; 17:174-183. Doi: 10.1016/S1470-2045(15)00467-2.

Dattani M., Heald R. J., Goussous G., Broadhurst J., São Julião G. P., Habr Gama A, et al. Oncological and Survival Outcomes in Watch and Wait Patients With a Clinical Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review and Pooled Analysis. Ann Surg. 2018; 268:955-67. Doi: 10.1097/SLA. 0000000000002761.

Dossa F., Chesney T. R., Acuna S. A., Baxter N. N. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis. Lancet

Gastroenterol Hepatol. 2017; 2:501-13. Doi: 10.1016/S2468-1253(17)30074-2.

Smith J. J., Strombom P., Chow O. S., Roxburgh C. S., Lynn P., Eaton A., et al. Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy. JAMA Oncol. 2019; 5:e185896. Doi: 10.1001/jamaoncol.2018.5896. PMID: 30629084;

Li J., Liu H., Yin J., Liu S., Hu J., Du F., et al. Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study. Oncotarget. 2015; 6:42354-61. Doi: 10.18632/ oncotarget.6093.

Descargas

Publicado

31-03-2026

Cómo citar

P. J. Paredes Cotoré, A. Parajó Calvo, & J. E. Casal Núñez. (2026). Tratamiento no quirúrgico: Watch and wait. Revista De Cirugía De Galicia, 10(14). Recuperado a partir de https://revista.proeditio.com/RevistaSociga/article/view/9070

Artículos similares

1 2 3 4 5 > >> 

También puede Iniciar una búsqueda de similitud avanzada para este artículo.